ARTICLE | Company News
Cerulean, Novartis deal
October 24, 2016 7:00 AM UTC
Cerulean partnered with Novartis to develop nanoparticle-drug conjugates (NDCs) using Cerulean’s Dynamic Tumor Targeting platform with undisclosed Novartis compounds against up to five targets. The pl...